NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $529,440,660 | +5.0% | 5,197,729 | +4.1% | 0.06% | +9.4% |
Q2 2023 | $504,043,914 | -28.0% | 4,994,985 | -34.3% | 0.05% | -26.4% |
Q1 2023 | $699,630,677 | +21.1% | 7,604,681 | +19.4% | 0.07% | +9.1% |
Q4 2022 | $577,830,008 | +5.3% | 6,369,378 | -11.7% | 0.07% | 0.0% |
Q3 2022 | $548,577,000 | -12.6% | 7,217,174 | -2.8% | 0.07% | -7.0% |
Q2 2022 | $627,572,000 | -9.1% | 7,424,251 | -5.6% | 0.07% | +6.0% |
Q1 2022 | $690,219,000 | +1.3% | 7,865,735 | +1.0% | 0.07% | +1.5% |
Q4 2021 | $681,242,000 | -9.6% | 7,788,298 | -15.5% | 0.07% | -15.4% |
Q3 2021 | $753,395,000 | -8.3% | 9,212,470 | +2.3% | 0.08% | -8.2% |
Q2 2021 | $821,311,000 | +4.6% | 9,001,642 | -2.0% | 0.08% | -3.4% |
Q1 2021 | $785,478,000 | -15.2% | 9,189,032 | -6.3% | 0.09% | -26.1% |
Q4 2020 | $926,387,000 | +31.5% | 9,810,302 | +21.1% | 0.12% | +24.0% |
Q3 2020 | $704,432,000 | -4.5% | 8,100,623 | -4.1% | 0.10% | -14.3% |
Q2 2020 | $737,597,000 | +3.4% | 8,445,111 | -2.3% | 0.11% | -12.5% |
Q1 2020 | $713,056,000 | -19.6% | 8,648,328 | -7.7% | 0.13% | +0.8% |
Q4 2019 | $887,350,000 | +21.4% | 9,371,109 | +11.4% | 0.13% | +16.5% |
Q3 2019 | $731,204,000 | -12.6% | 8,414,309 | -8.2% | 0.11% | -14.2% |
Q2 2019 | $836,972,000 | -3.8% | 9,166,269 | +1.3% | 0.13% | -5.9% |
Q1 2019 | $870,130,000 | +12.0% | 9,050,656 | -0.0% | 0.14% | -0.7% |
Q4 2018 | $776,909,000 | +24.6% | 9,053,828 | +25.1% | 0.14% | +40.2% |
Q3 2018 | $623,526,000 | +22.3% | 7,236,823 | +7.2% | 0.10% | +15.5% |
Q2 2018 | $509,860,000 | -6.6% | 6,749,533 | -0.1% | 0.08% | -9.7% |
Q1 2018 | $546,017,000 | -5.6% | 6,753,463 | -2.0% | 0.09% | -4.1% |
Q4 2017 | $578,675,000 | -22.9% | 6,892,269 | -21.2% | 0.10% | -18.5% |
Q3 2017 | $750,695,000 | +30.9% | 8,744,261 | +27.3% | 0.12% | +4.4% |
Q2 2017 | $573,449,000 | +5.4% | 6,870,122 | -6.3% | 0.11% | +5.6% |
Q1 2017 | $544,304,000 | +9.6% | 7,328,730 | +7.5% | 0.11% | +0.9% |
Q4 2016 | $496,790,000 | -0.6% | 6,820,295 | +7.7% | 0.11% | -2.7% |
Q3 2016 | $499,873,000 | -0.9% | 6,330,691 | +3.5% | 0.11% | -6.0% |
Q2 2016 | $504,615,000 | +19.0% | 6,115,806 | +4.4% | 0.12% | +13.6% |
Q1 2016 | $424,192,000 | -11.5% | 5,855,757 | +5.1% | 0.10% | -9.6% |
Q4 2015 | $479,212,000 | -7.7% | 5,569,642 | -1.4% | 0.11% | -11.6% |
Q3 2015 | $519,227,000 | +127.9% | 5,648,680 | +143.8% | 0.13% | +74.3% |
Q2 2015 | $227,873,000 | -1.2% | 2,317,192 | -0.9% | 0.07% | -5.1% |
Q1 2015 | $230,637,000 | +9.0% | 2,338,891 | +2.4% | 0.08% | +2.6% |
Q4 2014 | $211,658,000 | -4.3% | 2,284,244 | -2.8% | 0.08% | +5.6% |
Q3 2014 | $221,224,000 | +6.5% | 2,350,194 | +2.4% | 0.07% | +9.1% |
Q2 2014 | $207,789,000 | -5.4% | 2,295,247 | -11.2% | 0.07% | -19.5% |
Q1 2014 | $219,764,000 | -2.3% | 2,584,857 | -7.7% | 0.08% | +1.2% |
Q4 2013 | $225,048,000 | +2.5% | 2,799,815 | -2.2% | 0.08% | -6.9% |
Q3 2013 | $219,624,000 | +4.1% | 2,863,042 | -4.1% | 0.09% | -2.2% |
Q2 2013 | $211,046,000 | – | 2,984,658 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |